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Abstract 25 
Interest in the synthesis of procyanidin (catechin or epicatechin) oligomers that contain the 26 
4→8 interflavan linkage remains high, principally due to research into their health effects. A 27 
novel coupling utilizing a C8-boronic acid as a directing group was developed in the 28 
synthesis of natural procyanidin B3 (i.e. 3,4-trans-(+)-catechin-4α→8-(+)-catechin dimer). 29 
The key interflavan bond was forged using a novel Lewis acid-promoted coupling of C4-30 
ether 6 with C8-boronic acid 16 to provide the α–linked dimer with high diastereoselectivity. 31 
Through the use of a boron protecting group, the new coupling procedure was extended to the 32 
synthesis of a protected procyanidin trimer analogous to natural procyanidin C2.  33 
Keywords: iterative synthesis, procyanidin oligomers, Lewis acid-promoted coupling, benzyl 34 
ether, procyanidin B3, boron protection. 35 
36 
 4 
1. Introduction. 37 
1.1 Proanthocyanidins in nature and their significance. 38 
Proanthocyanidins, or condensed tannins, are a class of polyphenolic compounds that are 39 






 The term proanthocyanidins covers closely related compounds (differing in B ring 41 
substitution) termed procyanidins (catechol ring) or prodelphinidins (pyrogallol ring) (Figure 42 
1). The last two decades have seen an increasingly widespread interest in these compounds, 43 
principally due to their beneficial health effects.
2,5
 Such compounds have been reported to 44 




 activities, along with anti-tumor 45 
promoting and DNA polymerase inhibitory effects.
8
 Proanthocyanidins also play important 46 
functions in some sensorial properties of red wine, particularly in astringency
9
 and color 47 
stabilization.
10
  48 
Given the diversity of the compounds encompassed under the banner of proanthocyanidins, 49 
there has been a desire to understand the structure-activity relationships which may exist for 50 
their biological and sensorial properties.
11
 In order to study these relationships, pure, defined 51 
proanthocyanidin samples are required. As a consequence, synthesis from known starting 52 
materials has become an increasingly popular method used to obtain these compounds with 53 
known purities and defined structures. 54 
1.2 Procyanidin oligomer synthesis. 55 
The synthesis of procyanidin ((epi)catechin) oligomers that contain the 4→8 interflavan 56 
linkage has been of particular interest (e.g. procyanidin B3, Figure 1). In efforts to produce 57 
pure, defined oligomers, the iterative synthesis of such compounds has been the focus of a 58 
number of studies.
12,13
 However, efforts towards such iterative syntheses have been hampered 59 
due to the high chemical reactivity of these compounds,
12,14
 which tend to react non-60 
selectively to form polydisperse oligomeric mixtures. Controlling the degree of 61 
oligomerisation stands as the major challenge that needs to be addressed for successful 62 




Figure 1: Procyanidin B3 (1) and representative 4→8 proanthocyanidin oligomers depicted 66 
by 2. 67 
 68 
Dimers, the simplest of all proanthocyanidin oligomers, have been primary targets of many 69 
selective oligomer syntheses.
15
 Two notable selective syntheses of (epi)catechin dimers were 70 
reported by Ohmori et al.
12 
and Tarascou et al.
13 
Both used a C8-bromide (e.g. 3) which 71 
played a critical role in blocking the formation of higher oligomers, leading to the selective 72 
formation of the desired protected dimer(s) (e.g. 5, Scheme 1). 73 
Scheme 1: Dimer formation using a C8 bromide blocking group to prevent uncontrolled 74 
oligomerisation. 75 
 76 
Surprisingly, little attention has been focused on the use of C8-organometallic derivatives as 77 
directing groups for the selective synthesis of 4→8 oligomers. The only such report by 78 
Kozikowski et al. involved the addition of a C8-organolithium to a C4-ketone derivative.
16 79 
This synthesis ultimately resulted in the formation of an unnatural 3,4-cis-epicatechin-80 
 6 
epicatechin dimer. In this context, the synthesis of the 3,4-trans catechin-catechin dimer 81 
(procyanidin B3, 1) and iteration to analogous trimer were targeted using a C8-82 
organometallic derivative to direct the formation of the 4→8 interflavan bond (e.g. Scheme 83 
2). A C8-blocking group was viewed as an important component for controlled procyanidin 84 
synthesis. 85 
Scheme 2: Interflavan bond formation through Lewis acid-promoted condensation of C4-86 
ether 6 and a C8-organometallic 7. 87 
 88 
2. Results and discussion. 89 
2.1 Synthetic approach. 90 
Following a recent model study,
17
 the synthesis of the key 3,4-trans 4→8 interflavan bond 91 
was approached using the Lewis acid-promoted coupling strategy depicted in Scheme 3. 92 
Related couplings by Saito et al.
18 
have successfully employed this ethoxyethyl-C4-93 
ether/Lewis acid combination for the selective, high yielding syntheses of 3,4-trans 4→8 94 
linked (epi)catechin oligomers. In this case, the C8-bromide of C4-ether 6 was included to 95 
prevent formation of higher oligomers without requiring a large excess of nucleophile 7 96 
(Scheme 2). 97 
C4-Ether 6 was obtained in four steps from (+)-catechin (8) (Scheme 3). Benzyl protection of 98 
(+)-catechin (8) using NaH and BnCl in DMF employing a method adapted from Mustafa et 99 
al.
19
 furnished tetrabenzyl ether 9 in excellent yields (90-95%) using 5-10 g of 8. DDQ-100 
mediated C4-oxidation of 9 using the method described by Saito et al.
18b
 afforded the desired 101 
C4-β-ether 10 in 85% crude yield as a single stereoisomer (by 1H NMR). Treatment of crude 102 
C4-ether 10 with one equivalent of NBS, followed by benzylation of the C3-OH provided the 103 
 7 
desired C4-ether 6 in 94% yield (76% overall yield in 4 steps) following purification by silica 104 
chromatography. 105 
Scheme 3: Synthesis of C4-ether 6 from (+)-catechin (8). 106 
 107 
2.2 Couplings of C4-ether 6 with model organometallic reagents. 108 
Successful coupling of the C4-ether 6 required an appropriate organometallic 7 (Scheme 2) 109 
to use in the Lewis acid-promoted 4→8 coupling reaction. This was initially explored using 110 
the model system depicted in Scheme 4. 2,4,6-Trimethoxyphenylmetal derivatives 11 and 12 111 
were chosen as suitable model species due to their identical phenyl ring oxygenation pattern 112 
to that of a C8-organometallic species such as 7 derived from (+)-catechin (8). 113 
Scheme 4: Model system Lewis acid-promoted coupling of C4-ether 6 with 2,4,6-114 
trimethoxyphenylmetal species 11 or 12. 115 
 116 
After trialling numerous organometallic species 11 (M = Li, Mg, Cu, Zn) without success, 4-117 




 (12) (M = B(OH)2) with C4-ether 6 (Scheme 4). The 119 
reaction product 13 contained 5-10% of an inseparable impurity. While the identity of the 120 
impurity was not confirmed, it was presumed to be the non-brominated 4-arylflavan moiety 121 
14. To the best of our knowledge the coupling of 6 and 12 represents the first such report of a 122 
Lewis acid-promoted coupling of an arylboronic acid with a benzyl ether. Notably, the 123 
desired 3,4-trans isomer of 13 was produced in >90% diastereomeric excess using this 124 
method. A ROESY NMR experiment confirmed this stereochemistry. An rOe interaction was 125 
observed between C2-H and C4-H, which showed that these two protons were on the same 126 
side of the heterocyclic C-ring. (Scheme 4) This rOe indicated that 13 possessed the desired 127 
3,4-trans stereochemistry, with further confirmation provided by the large H3-H4 coupling 128 
constant (J = 8.2 Hz). Since the concept of using a C8-organometallic in a 4→8 style 129 
coupling was confirmed with model boronic acid 12, compound 13 was used without further 130 
purification. 131 
2.3 Synthesis of C8-boronic acid 16 and its application in 4→8 dimer synthesis. 132 
After the successful application of boronic acid 12 in the synthesis of 4-arylflavan 13, 133 
attention then turned towards using this method to produce the protected catechin-catechin 134 





in good yields (Scheme 5). This was accomplished by low temperature lithium-halogen 136 
exchange of 15 with n-butyl lithium in THF, followed by transmetallation with excess 137 
B(OMe)3. In situ aqueous hydrolysis provided boronic acid 16. This series of transformations 138 
showed a marked scaling effect. No boronic acid 16 was formed using less than 0.5 mmol of 139 
the starting bromide 15. Above this seemingly critical point, the isolated yield of boronic acid 140 
16 increased as the amount of bromide 15 was increased. When conducted using 1 to 3 grams 141 
of 15, boronic acid 16 was routinely isolated in 60-65% yield after silica chromatography. 142 
The 
11
B NMR spectrum of 16 displayed a broad peak at 29.1 ppm, which was indicative of 143 
the presence of a boronic acid.
21
 Additionally, no C8 resonance was observed in the 
13
C 144 
NMR spectrum of 16. This indicated the presence of a boron atom attached to C8, as 145 
resonances of carbon atoms attached to boron are not observed in 
13
C NMR spectra due to 146 
quadrupolar relaxations through the carbon-boron bond.
21
 These observations, combined with 147 
further NMR and HRMS data led to the assignment of 16 as the desired C8-boronic acid. 148 
 149 
 9 
Scheme 5: Formation of C8-boronic acid 16 and subsequent coupling to C4-ether 6 to 150 
synthesise dimer 5. 151 
 152 
The key 4→8 bond of dimer 5 was constructed in excellent yields using the developed 153 
TMSOTf-mediated coupling of C4-ether 6 with C8-boronic acid 16 (Scheme 5). C4-Ether 6 154 
was completely consumed in the reaction to form dimer 5 using only a slight excess (1.1 155 
equivalent) of boronic acid 16. Using these coupling conditions, dimer 5 was consistently 156 
synthesised in 90-95% yields regardless of the coupling scale, and gram quantities of 5 were 157 
successfully prepared. Additionally, the coupling temperature and reaction time were 158 
identical to that used in the synthesis of 4-arylflavan 13 (Scheme 4). This suggested that the 159 
greater steric encumbrance of boronic acid 16 compared to that of the model boronic acid 12 160 
appeared to have no detrimental effect on the coupling reaction. The coupling of 16 and 6 161 
also exhibited excellent 3,4-trans stereoselectivity for dimer 5 (>90% by 
1
H NMR). By 162 
analogy with the stereochemical studies of 13, NMR ROESY experiments performed on 5 163 
showed that C2-H and C4-H of the upper, or C8-terminus catechin unit were on the same side 164 
of the heterocyclic C-ring. This confirmed the desired 3,4-trans nature of the new 4→8 165 
interflavan bond, as did the large H3-H4 coupling constant (J = 8.2 Hz). 166 
2.4 Completion and confirmation of procyanidin B3 synthesis. 167 
To complete the synthesis of procyanidin B3 (1), the bromide and benzyl protecting groups 168 
of dimer 5 were removed in a one pot hydrogenolysis process. Using the conditions reported 169 
by Tarascou et al.,
13
 Pd(OH)2-mediated hydrogenolysis of dimer 5 in the presence of excess 170 
triethylamine afforded the desired (+)-catechin-4α→8-(+)-catechin dimer, or procyanidin B3 171 




Scheme 6: Synthesis of procyanidin B3 (1) through one-pot deprotection of dimer 5. 175 
 176 




C NMR data and the optical rotation of the synthetic material to 177 
that reported for the same compound by Saito et al.
18
 and the melting point data reported by 178 
Tarascou et al.
13
 confirmed the identity of procyanidin B3 (1) as synthesised and that the 179 
natural 3,4-trans stereochemistry was obtained. On the whole, the novel application of 180 
boronic acid 16 and C4-ether 6 in a Lewis acid-mediated coupling provided a smooth 181 
transition to natural product 1 from catechin (8) in 54% overall yield in 6 linear steps. 182 
2.5 Attempted extension of method to higher oligomers. 183 
The most obvious route for extending the new method to the synthesis of trimeric species was 184 
to convert dimeric bromide 5 to the corresponding dimeric boronic acid 17. This boronic acid 185 
could then conceptually undergo a further Lewis acid-promoted coupling with C4-ether 6 to 186 
produce a trimer. The conversion of 5 to boronic acid 17 was attempted using the 187 
transmetallation conditions applied to the synthesis of boronic acid 16 (Scheme 7). Using 188 
these conditions, 17 was never obtained and the debrominated analogue of dimer 5 was the 189 
only product isolated from this reaction, indicating that transmetallation to the boronate did 190 
not occur. 191 
Scheme 7: Attempted formation of dimeric boronic acid 17 from bromide 5. 192 
 193 
 11 
It was apparent there was an issue with attempting to manipulate functional groups at the 194 
dimer stage of the iterative synthesis. As a result, the method required amending so all the 195 
important functional group manipulations were undertaken on the monomeric species. 196 
2.6 Boronic acid protection strategies. 197 
Recently, methods for the iterative synthesis of oligoarene species have been developed by 198 
Gillis et al.
21
 and Noguchi et al.
22
. These strategies involved the use of boron protecting 199 
groups to perform iterative Suzuki cross-couplings, as depicted in Scheme 8. Such a strategy 200 
seemed amenable to the iterative synthesis of catechin oligomers. 201 
Scheme 8: Representation of boron protection strategy in iterative oligoarene synthesis. 202 
 203 
2.7 Application of boron protection strategy to catechin oligomers. 204 
2.7.1 Synthesis of “chain extension” catechin unit. 205 
Before any attempt to apply a boron protection strategy to the synthesis of catechin 206 
oligomers, an appropriate protecting group was required and a boron-protected C4-ether had 207 
to be synthesised. The N-methyliminodiacetic acid (MIDA) group as used by Gillis et al.
20
 208 
was chosen as this boronic acid protection employed mild conditions and the protecting 209 
group was predicted to be stable under the Lewis acid coupling conditions used earlier 210 
(Section 2.3). 211 
Synthesis of the C8-boron-protected C4-ether 19 was achieved in two steps from the 212 
previously prepared C4-ether 6. Initially, C 4-ether 6 was converted to C8-boronic acid 18 in 213 
50-55% yields using the same method described for the preparation of C8-boronic acid 16. 214 
Refluxing boronic acid 18 in toluene/DMSO in the presence of MIDA and CaH2 afforded the 215 
boron-protected species 19 in 75-80% yields after purification (Scheme 9). 216 
 217 
 12 






C NMR spectra of 19 showed several diagnostic features. For the 
11
B NMR 220 
spectra, the broad peak observed at 29.5 ppm for boronic acid 18 shifted to a narrower peak 221 
at 12.7 ppm for the MIDA protected equivalent 19. This observed shift was consistent with 222 
that reported by Gillis et al. for tetrahedral, MIDA-protected boron species.
21
 The shifts at 223 
167.9 ppm and 46.9 ppm observed in the 
13
C NMR spectrum of 19 were indicative of the 224 
carbonyl and N-methyl groups of the attached MIDA group, respectively. These key features, 225 




C NMR spectra and HRMS data, 226 
confirmed C4-ether 19 had the assigned structure.   227 
This boron-protected species was dubbed the “chain extension” unit 19 as it was proposed 228 
this species could be serially coupled to the C8-terminus of a growing catechin oligomer by 229 
repeated coupling and deprotection steps (as indicated in Scheme 8 for oligoarenes). Most 230 
significantly, the key bromide-to-boron conversion of 18 was achieved using a monomeric 231 
unit. This alleviated any necessity to perform functional group manipulations of higher 232 
oligomers, thereby overcoming the issue outlined in Section 2.5. As a result, it was 233 
anticipated that this route, using “chain extension” unit 19, would be applicable to the 234 
iterative synthesis of catechin oligomers. 235 
2.7.2 Use of “chain extension” unit 19 in dimer formation. 236 
The utility of “chain extension” unit 19 in an iterative oligomer synthesis was validated 237 
through its coupling to C8-boronic acid 16 (Scheme 10). This coupling was completed using 238 





Scheme 10: Lewis acid-promoted coupling of “chain extension” unit 19 to boronic acid 16. 243 
 244 
The boron-protected dimer 20 was consistently synthesised in excellent yields (90-95%) and 245 
the reaction was applicable to gram-scale synthesis of dimer 20. The diagnostic C4 and C8 246 
peaks at 36.7 ppm and 112.6 ppm in the 
13
C NMR spectrum of dimer 20 indicated that the 247 
4→8 bond was successfully forged. The 11B NMR spectrum showed a peak at 13.5 ppm, 248 
which showed that the C8-boron atom of the top unit was still present as the MIDA-protected 249 
species. This observation confirmed the protective utility of the MIDA group during the 250 
Lewis acid-promoted coupling. 251 
2.7.3 Deprotection of dimer 20 and synthesis of trimer. 252 
Prior to testing the utility of the boron-protection and coupling strategy in the synthesis of 253 
higher oligomers, dimer 20 required deprotection to the free boronic acid 17. Stirring dimer 254 
20 in THF/aqueous NaOH at room temperature removed the MIDA group, while filtration of 255 
the reaction mixture over SiO2 and concentration provided the free boronic acid dimer 17 in 256 
85% crude yield (Scheme 11).  257 
Scheme 11: Deprotection of dimer 20 and subsequent Lewis acid-promoted coupling to 258 
“chain extension” unit 19. 259 
 260 
 14 
The synthesis of trimer 21 was completed by the Lewis acid-promoted coupling of the free 261 
boronic acid dimer 17 with another equivalent of “chain extension” unit 19. This coupling 262 
afforded a product tentatively assigned as trimer 21, in 90% crude yield (Scheme 11). 263 
Unfortunately, residual solvents, particularly aliphatic hydrocarbons from silica 264 
chromatography, could not be completely removed from trimer 21. These residual solvents 265 
coincided with some peaks in the NMR spectra of 21, particularly in the 1-3 ppm and 0-30 266 




C spectra respectively. However, several indicative features of 267 
the spectral data pointed towards the successful formation of trimer 21 as depicted in Scheme 268 
11. Firstly, the HRMS data was consistent with that expected for the MIDA protected trimer 269 
21. Furthermore, the C4 and C8 resonances of the interflavan bonds at 36.7 and 36.9 ppm, 270 
and 112.6 and 112.8 ppm, respectively, in the 
13







 for similar 4→8 linked (epi)catechin 272 
trimers and higher oligomers. The narrow peak at 13.7 ppm in the 
11
B NMR spectrum and the 273 
carbonyl and N-methyl resonances at 168 and 47 ppm indicated that C8 of the uppermost unit 274 
was still attached to the B-MIDA group as expected. These data led to the tentative 275 
assignment of the product as trimer 21. Attempts were made to remove the boron and benzyl 276 
groups to obtain the natural procyanidin C2, but due to the small quantity of trimer 21 277 
synthesised, this was not achieved. 278 
Nonetheless, the successful synthesis of a compound that is entirely consistent with trimer 21 279 
shows two important things. Firstly, through the use of the boron protecting group, the novel 280 
Lewis acid-promoted coupling strategy is applicable to the synthesis of dimeric and trimeric 281 
catechin oligomers. Secondly, the “chain extension” unit 19 has been used successfully in 282 
two coupling events. It is not unreasonable, therefore, to envisage this unit could be 283 
sequentially used in Lewis acid-promoted couplings with other oligomeric C8-boronic acid 284 
species to produce oligomers beyond that of the trimer reported here. 285 
3. Conclusions 286 
A novel Lewis acid-promoted coupling of a benzylic ether to an aryl boronic acid was 287 
developed for its use in the synthesis of 4→8 catechin oligomers. Initially, this method was 288 
used in the synthesis of the dimer procyanidin B3 (1) from (+)-catechin (8) in good overall 289 
yield (54% over 6 steps). The key 4→8 interflavan bond was formed in excellent yields (90-290 
95%) by the stereoselective Lewis acid-promoted coupling of C4-ether 6 with C8-boronic 291 
acid 16. This represents the first synthesis and use of C8-boronic acid 16 in the formation of a 292 
 15 
natural procyanidin dimer. Combining the Lewis acid-promoted coupling with a boron 293 
protection-coupling-deprotection strategy, the synthetic method was extended to the iterative 294 
synthesis of dimer and trimer species. This was achieved by sequential addition of “chain 295 
extension” unit 19 to a growing oligomer chain. Further studies are currently being 296 
undertaken towards the extension of these methods in the iterative synthesis of higher 297 
oligomers, along with examination of the mechanism for the novel Lewis acid-promoted 298 
coupling reaction. 299 
4. Experimental. 300 
4.1 General Procedures. 301 
4.1.1 Materials: Commercial reagents were purchased from Sigma-Aldrich and used without 302 
further purification unless noted. THF was distilled from sodium/benzophenone ketyl and 303 
CH2Cl2 and triethylamine from CaH2 under an atmosphere of nitrogen prior to use. DMF was 304 
purchased as Sureseal
©
 anhydrous reagent from Sigma-Aldrich and used as received under an 305 
atmosphere of nitrogen or argon. N-Bromosuccinimide (NBS) was recrystallised from hot 306 
water prior to use. n-BuLi was used as received as a solution in hexanes and titrated 307 
according to the method of Suffert 
25
 either prior to use or on a weekly basis when in regular 308 
use. 2,4,6-Trimethoxyphenylboronic acid (12) was prepared according to the procedure 309 
described by Dennis et al.
17
 310 
4.1.2 Experimental Procedures: All reactions were conducted using anhydrous solvents 311 
under an argon atmosphere and performed in oven dried round bottom or vial flasks fitted 312 
with a rubber subaseal unless otherwise stated. Organic solutions were concentrated with 313 
rotary evaporation under reduced pressure. Thin layer chromatography (TLC) was performed 314 
using the indicated solvent systems on E. Merck silica gel 60 F254 plates (0.25mm). 315 
Compounds were visualised by exposure to UV light (= 254nm) and developed by dipping 316 
in a KMnO4 solution followed by brief heating using a heat gun. Silica gel chromatography 317 
was conducted using E. Merck silica gel (230-400 mesh). 318 
4.1.3 Spectral and structural analysis: 
1
H NMR spectra were recorded on one of the 319 
following instruments: Bruker Avance III 600 or 400 MHz or Varian Gemini 300 MHz. 320 
Chemical shifts are reported in parts per million (ppm) downfield from tetramethylsilane and 321 
referenced to residual protons in the NMR solvent (CHCl3, δ = 7.26; CD2HOD, δ = 3.31, 322 
centre line). Data is reported as the following: chemical shift, multiplicity (s = singlet, d = 323 
 16 
doublet, t = triplet, q = quartet, m = multiplet, br = broad, app = apparent, dis = distorted), 324 
integration and coupling constant (J, Hz). 
13
C NMR spectra were recorded on one of the 325 
following instruments: Bruker Avance III 600 (at 150MHz) or 400 MHz (at 100 MHz), 326 
Varian Gemini 300 MHz (at 75 MHz). Chemical shifts are reported in ppm downfield from 327 
tetramethylsilane and referenced to the carbon resonances in the NMR solvent (CDCl3, δ = 328 
77.0, centre line; CD3OD, δ = 49.1, centre line). Carbons bearing boron substituents were not 329 
observed (quadrupolar relaxation). 
11
B NMR were recorded on a Bruker Avance 400 (at 128 330 
MHz) at 60 
o
C and referenced to an external standard (BF3.OEt2) using CD3CN as the 331 
solvent. An acquisition time of 0.15 s and recycle delay of 0.1 s were used. High resolution 332 
mass spectra (HRMS) were performed at the Monash University Mass Spectrometry Unit 333 
using a Micromass ‘Quattro micro’ instrument using electrospray ionisation (ESI) technique. 334 
Infrared spectra were recorded on a BIO-RAD FTS-40A Fourier Transform 335 
spectrophotometer with the absorptions recorded in wavenumbers (cm
-1
). Samples were 336 
analysed as thin films on NaCl discs. Optical rotations were measured with a PolAAR 21 337 
polarimeter, referenced to the sodium D line (589 nm) at 20 °C, using the spectroscopic grade 338 
solvents specified and at the concentrations (c, g/100mL) indicated. The measurements were 339 
carried out in a cell with a 1 dm path length. Melting points were recorded on a Reichert hot-340 
stage apparatus. 341 
4.2 Synthetic procedures. 342 
4.2.1 5,7,3´,4´-tetra-O-benzyl-(+)-catechin (9). 343 
The title compound was prepared by an adaption of the procedure for the same compound 344 
reported by Mustafa et al.
19
 345 
To a stirring solution of (+)-catechin 8 (9.70 g, 33.4 mmol) in DMF (200 mL) at 78 oC, NaH 346 
(5.7 g, 60 % dispersion in mineral oil, 142 mmol, 4.25 equiv.) was added as a solid, followed 347 
immediately by neat BnCl (20.0 mL, 173 mmol, 5.2 equiv.). The resulting mixture was 348 
stirred vigorously at 78 oC for 15 minutes, then the cold bath was removed and stirring was 349 
continued at room temperature for 7 hours. The mixture was poured into EtOAc (400 350 
mL)/water (600 mL) and stirred vigorously for 30 minutes. The phases were then separated 351 
and the organic layer was washed with brine (5 × 100 mL), then dried (Na2SO4), filtered and 352 
concentrated. The brown residue was purified by filtration over SiO2 (CH2Cl2/hexane 1:1 353 
eluted mineral oil and excess BnCl, then CH2Cl2 eluted product) to provide the tetrabenzyl 354 
 17 
product (20.5 g, 94%) as a white, crystalline solid after removal of the solvent. The 
1
H and 355 
13
C NMR spectra of the product corresponded to that reported by Mustafa et al. for the title 356 
compound 9.
19 357 
4.2.2 (2R,3S,4S)-5,7,3´,4´-tetrabenzyloxy-4-(2˝-ethoxy-ethoxy)-flavan (10). 358 
The title compound was prepared by an adaption of the procedure for the same compound 359 
reported by Saito et al.
18b
 360 
To a stirring solution of 9 (2.02 g, 3.11 mmol) and 2-ethoxyethanol (5 mL) in CH2Cl2 (50 361 
mL) at 0 
o
C, DDQ (1.42 g, 6.25 mmol) was added slowly and the resulting blue/purple 362 
mixture was stirred for 2 hours at room temperature. The reaction mixture was poured into a 363 
mixture of sat. aq. NaHCO3 (500 mL)/CH2Cl2 (100 mL) and vigorously stirred for 30 minutes 364 
before the phases were separated. The organic layer was sequentially washed with sat. aq. 365 
NaHCO3 (100 mL), water (100 mL), and brine (100 mL), then dried (Na2SO4), filtered and 366 
concentrated. The blue/green residue was then filtered over SiO2 (CHCl3) to provide ether 10 367 
as an orange solid (1.95 g, 85%) after solvent removal. The compound was of sufficient 368 




C NMR spectra of the product 369 
corresponded with that reported by Saito et al. for the title compound 10.
18b
 370 
4.2.3 (2R,3S,4S)-8-bromo-3,5,7,3´,4´-pentabenzyloxy-4-(2˝-ethoxy-ethoxy)-flavan (6). 371 
To a stirring solution of 10 (2.36 g, 3.20 mmol) in CH2Cl2 (30 mL) at 0 
o
C, NBS (573 mg, 372 
3.21 mmol) was added as a solid. The mixture was allowed to slowly warm to room 373 
temperature with stirring over 4 hours. The mixture was quenched by the addition of aq. 374 
Na2S2O3.5H2O (1 g in 30 mL water) and the resulting mixture was vigorously stirred at room 375 
temperature for 10 minutes and the phases were separated. The aqueous phase was then 376 
extracted with CH2Cl2 (2 × 50 mL) and the combined organic extracts were dried (Na2SO4), 377 
filtered and concentrated to afford 2.59 g (99%) of a crude yellow/orange solid. This crude 378 
product was immediately dissolved in anhydrous DMF (30 mL) and cooled to 0 
o
C with 379 
stirring. NaH (195 mg, 60% dispersion in oil, 4.88 mmol) was added as a solid, which 380 
resulted in the immediate formation of a cloudy, deep yellow suspension. The resulting 381 
mixture was stirred at 0 
oC for 30 minutes and neat BnBr (570 μL, 4.80 mmol) was added. 382 
The cold bath was then removed and stirring was continued at room temperature for 3 hours. 383 
The mixture was then poured into EtOAc (100 mL)/water (100 mL) and stirred vigorously for 384 
30 minutes. The phases were separated and the organic phase was washed with brine (3 × 100 385 
 18 
mL), then dried (Na2SO4), filtered and concentrated. The product was then isolated by 386 
gradient silica gel chromatography (EtOAc/hexanes 1:9 to 1:4) to provide title compound 6 387 
(2.73 g, 95%) as a white foamy solid after solvent removal. 
1
H NMR (300 MHz, CDCl3) δ 388 
7.48-7.26 (m, 20H), 7.19-6.94 (m, 8H), 6.22 (s, 1H, C6-H), 5.36 (d, 1H, J = 10.2 Hz, C2-H), 389 
5.19 (s, 2H), 5.08 (br s, 4H), 5.01 (d, 2H, J = 10.2 Hz), 4.85 (d, 1H, J = 2.4 Hz, C4-H), 4.22 390 
(d, 1H, J = 12 Hz, C3- O-CH2-Ph), 4.06 (d, 1H, J = 12 Hz, C3- O-CH2-Ph), 4.06-3.95 (m, 391 
1H), 3.90-3.77 (m, 1H), 3.60-3.40 (m, 5H), 1.15 (t, 3H, J = 7.2 Hz, C4-OCH2CH2-392 
OCH2CH3). 
13
C NMR (75 MHz, CDCl3) δ 156.9, 156.6, 152.3, 148.9, 148.7, 137.6, 137.3, 393 
137.2, 136.4, 136.3, 132.1, 128.5-126.8 (Benzyl Ar-H), 120.9, 114.7, 114.1, 105.5, 92.6 394 
(C8), 92.1 (C6), 78.6 (C2), 75.5 (C3), 71.8 (C4), 71.3, 70.99, 70.95, 70.6, 70.4, 69.8, 67.4, 395 




], 929.2660; found, 929.2665. 396 
4.2.4 (2R,3S,4R)-8-bromo-3,5,7,3´,4´-pentabenzyloxy-4-(2˝,4˝,6˝-trimethoxyphenyl)-flavan 397 
(13). 398 
To a stirring solution of 6 (0.19 g, 0.21 mmol) and 2,4,6-trimethoxyphenyl boronic acid (12) 399 
(52 mg, 0.24 mmol) in THF (3 mL) at 78 oC, neat TMSOTf (45.0 μL, 0.25 mmol) was 400 
added dropwise. Stirring was continued for 1 hour at 78 oC, and then the mixture was 401 
allowed to warm to room temperature in the cold bath over 3 hours. The mixture was poured 402 
into sat. aq. NaHCO3 (10 mL)/EtOAc (20 mL) and stirred vigorously for 10 minutes. The 403 
phases were separated and the organic phase was sequentially washed with water (20 mL) 404 
and brine (20 mL), then dried (Na2SO4), filtered and concentrated. The residue was then 405 
purified by silica gel chromatography (EtOAc/hexanes 1:4) to provide title compound 13 406 
(190 mg, 90%) as a white foamy solid after solvent removal. 
1
H NMR (600 MHz, CDCl3) 407 
90:10 mixture of major and minor product. δ (major product only) 7.51-7.24 (m, 19H), 7.18-408 
7.08 (m, 4H), 7.01 (d, 1H, J = 8.3 Hz), 6.97 (m, 2H), 6.70 (d, 2H, J = 7 Hz), 6.14 (s, 1H, C6-409 
H), 6.04 (br s, 1H, TMB C-H), 5.98 (br s, 1H, TMB C-H), 5.25 (s, 2H, O-CH2-Ph), 5.17 (q, 410 
2H, J = 12 Hz, O-CH2-Ph), 5.06 (d, 1H, J = 12 Hz, O-CH2-Ph), 5.04 (d, 1H, J = 12 Hz, O-411 
CH2-Ph) 4.85 (d, 1H, J = 8.2 Hz, C4-H), 4.78 (d, 1H, J = 11.5 Hz, O-CH2-Ph), 4.68 (d, 1H, J 412 
= 9.72 Hz, C2-H), 4.55 (d, 1H, J = 11.5 Hz, O-CH2-Ph), 3.95 (dd, 1H, J = 9.7 and 8.2 Hz, 413 
C3-H), 3.82 (s, 3H, TMB-OMe), 3.72 (d, 1H, J = 6 Hz, O-CH2-Ph), 3.59 (d, 1H, J = 6 Hz, 414 
OCH2Ph), 3.47 (br s, 3H, TMB-OMe), 3.36 (br s, 3H, TMB-OMe). 
13
C NMR (125 MHz, 415 
CDCl3) δ (major isomer only) 159.3 (TMB-Cq-OMe), 159.2 (TMB-Cq-OMe), 158.3 (TMB-416 
Cq-OMe), 156.0, 153.9, 153.7, 148.56, 148.51, 137.8, 137.33, 137.24, 136.8, 136.6, 132.4, 417 
 19 
129-126 (Benzyl Ar-H), 120.6, 114.7, 114.2, 113.5, 111.3, 94.5 (C8), 92.7 (C6), 91.7 (TMB-418 
C-H), 90.9 (TMB-C-H), 81.4 (O-CH2-Ph), 81.3 (C2), 73.9 (C3), 71.3 (O-CH2-Ph), 71.07 (O-419 





], 1007.2765; found 1007.2767. FTIR (thin film): 3062, 3031, 2935, 421 
2876, 2836, 1599, 1513, 1496, 1454, 1415, 1338, 1203, 1120, 1027, 811, 736, 698. 422 
4.2.5 3,5,7,3´,4´-penta-O-benzyl-(+)-catechin (4). 423 
The title compound was prepared by an adaption of the procedure described above for 424 
5,7,3´,4´-tetra-O-benzyl-(+)-catechin (9). 425 
NaH (4.67 g, 117 mmol, 60% dispersion in mineral oil, 6 equiv.) and BnCl (15.6 mL, 135 426 
mmol, 7 equiv.) were added to a solution of (+)-catechin 8 (5.61 g, 19.3 mmol) in DMF (120 427 
mL) at 78 oC. The resulting mixture was stirred at 78 oC for 15 minutes, then warmed to 428 
room temperature and stirred for a further 24 hours. The mixture was then quenched and 429 
extracted using the same procedure as for that of 9. Filtration of the residue over SiO2 430 
(CH2Cl2/Hexane 1:1 eluted mineral oil and excess BnCl, then CH2Cl2 eluted product) 431 








4.2.6 8-bromo-3,5,7,3´,4´-penta-O-benzyl-catechin (15). 435 
The title compound was prepared by an adaption of the procedure for the same compound 436 
reported by Kozikowski et al.
16
 437 
To a stirring solution of 4 (4.98 g, 6.7 mmol) in CH2Cl2 (100 mL) at 0 
o
C, NBS (1.32 g, 7.4 438 
mmol) was added as a solid. The mixture was then allowed to slowly warm to room 439 
temperature in the ice bath with continuous stirring for 4 hours. The reaction was quenched 440 
by the addition of aq. Na2S2O3.5H2O (1 g in 30 mL water) and the resulting mixture was 441 
vigorously stirred at room temperature for 10 minutes. The phases were separated and the 442 
aqueous phase was extracted with CH2Cl2 (2 × 20 mL). The combined organic extracts were 443 
dried (Na2SO4), filtered and concentrated. Filtration of the residue over SiO2 (CH2Cl2) 444 









4.2.7 3,5,7,3´,4´-penta-O-benzyl-catechin-8-boronic acid (16). 448 
To a stirring solution of 16 (2.09 g, 2.56 mmol) in THF (25 mL) at 78 oC, n-BuLi (2.10 mL, 449 
1.35 M in hexanes, 2.84 mmol) was added dropwise over 2 minutes. The resulting deep 450 
yellow solution was stirred at 78 oC for 15 minutes, then neat B(OMe)3 (600 μL, 5.38 451 
mmol) was added dropwise over 5 minutes. The resulting mixture was allowed to stir at 78 452 
o
C for 1 hour, before being slowly warmed to 0 
o
C in the cold bath over 4 hours. Water (5 453 
mL) was then added dropwise over 10 minutes with stirring and the resulting mixture was 454 
poured into EtOAc (100 mL)/ice (ca. 50 g) and allowed to warm to room temperature with 455 
stirring over 30 minutes. The phases were separated and the organic layer was washed 456 
sequentially with water (25 mL) and brine (25 mL), then dried (Na2SO4), filtered and 457 
concentrated. Purification of the orange residue by gradient silica chromatography 458 
(EtOAc/hexanes 1:4 to 1:2) provided boronic acid 17 (1.30 g, 65%) as a white, foamy solid 459 
after solvent removal. 
1
H NMR (400 MHz, CDCl3) δ 7.31-7.22 (m, 23H), 7.05-6.93 (m, 7H), 460 
6.27 (s, 1H, C6-H), 5.19 (s, 2H), 5.11-5.07 (m, 6H), 4.85 (d, 1H, J = 8.04 Hz, C2-H), 4.28 461 
(d, 1H, J = 12 Hz, C3-O-CH2-Ph), 4.14 (d, 1H, J = 12 Hz, C3-O-CH2-Ph), 3.73 (m, 1H, C3-462 
H), 3.03 (dd, 1H, J = 16.6 and 5.6 Hz, C4-H), 2.70 (dd, 1H, J = 16.6 and 8.7 Hz, C4-H). 
13
C 463 
NMR (100 MHz, CDCl3) δ164.1, 160.4, 159.6, 149.1, 149.0, 137.7, 137.1, 137.0, 136.3, 464 
135.5, 131.2, 130-125 (Benzyl Ar-H), 120.2, 115.0, 113.4, 103.4, 91.3 (C6), 80.7 (C2), 73.8 465 
(C3), 71.6, 71.3 (x2), 71.2, 70.0, 26.1 (C4). 
11
B NMR (126 MHz, CD3CN) δ 29.1. HRMS 466 




], 802.3546; found, 802.3553. FTIR (thin film): 467 
3519, 3063, 3032, 2928, 2871, 1600, 1580, 1515, 1497, 1454, 1426, 1302, 1265, 1174, 1098, 468 
1027, 763, 697.  469 
4.2.8 8-bromo-3,5,7,3´,4´-penta-O-benzyl-catechin-4α→8-3,5,7,3´,4´-penta-O-benzyl-470 
catechin (5). 471 
To a stirring solution of 6 (0.65 g, 0.71 mmol) and 17 (0.66 g, 0.89 mmol) in THF (7 mL) at 472 
78 oC, neat TMSOTf (140 μL, 7.7 mmol) was added dropwise and stirring was continued at 473 
78 oC for 1 hour. The reaction was then allowed to warm to room temperature in the cold 474 
bath over 3 hours. The mixture was poured into sat. aq. NaHCO3 (10 mL)/EtOAc (30 mL) 475 
and stirred vigorously for 10 minutes. The phases were separated and the organic phase was 476 
sequentially washed with water (20 mL) and brine (20 mL), then dried (Na2SO4), filtered and 477 
concentrated. The residue was then purified by silica gel chromatography to provide dimer 5 478 
(1.05 g, 95%) as a white foamy solid after solvent removal. 
1
H NMR (600 MHz, CDCl3, two 479 
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rotamers: maj:min ~75:25) δ 7.61-6.86 (m, Ar-H, B, E-ring-H, maj and min) 6.79-6.74 (m, 480 
B, E-ring-H, maj and min), 6.65 (d, J = 7.2 Hz), 6.58 (d, J = 7.2 Hz) 6.43 (m, maj and min), 481 
6.37 (s, D6-H, min), 6.31 (s, D6-H, maj), 6.22 (s, A6-H, maj), 6.15 (s, A6-H, min), 5.30-4.52 482 
(m, O-CH2-Ph, maj and min), 4.89 (d, J = 8.2 Hz, C4-H, maj), 4.65 (d, J = 9.3 Hz, C2-H, 483 
maj and min), 4.26 (d, J = 12 Hz, O-CH2-Ph, maj), 4.18 d, J = 12 Hz, O-CH2-Ph, maj), 4.08 484 
(dd, J = 9.3 and 8.2 Hz, C3-H, maj), 4.03-3.94 (m, C3-H, min and O-CH2-Ph, min), 3.83 (d, 485 
J = 11.52 Hz, C3-O-CH2-Ph, maj), 3.74 (d, J = 9.2 Hz, F2-H, maj), 3.59 (d, J = 11.52 Hz, 486 
C3-O-CH2-Ph, maj), 3.51-3.42 (m), 3.35 (d, J = 10.6 Hz), 3.26 (dd, J = 15.9 and 5.8 Hz, F4-487 
H, maj), 3.21 (dd, J = 15.9 and 5.8 Hz, F4-H, min), 2.68 (dd, J = 16.4 and 10.1 Hz, F4-H, 488 
min), 2.54 (dd, J = 16.4 and 10.1 Hz, F4-H, min) 
13
C NMR (125 MHz, CDCl3) (major isomer 489 
only) δ 157-153, 149-148 (C-B3΄, C-B4΄, C-E3΄, C-E4΄, maj and min), 138.5-133.6 (Bn 490 
CqPh, maj and min), 133.1, 132.6, 132.1, 131.6, 130-127 (Benzyl Ar-H, maj and min), 491 
121.2, 120.53, 120.45, 119.6, 115.3, 114.8, 114.5, 114.3, 113.8, 113.1, 112.6, 112.0 (C-D8, 492 
min), 112.0 (C-D8, maj), 110.9, 110.8, 93.39 (C-A8, maj), 93.94 (C-A8, min), 93.28-93.27 493 
(C-A6, maj and min), 93.10 (C-D6, min), 90.88 (C-D6, maj), 81.6 (C-C2, maj), 81.1 (C-C2, 494 
min), 80.8 (C-F2, maj), 79.6 (C-F2, min), 79.2, 78.4, 75.5, 75.1, 74.4, 72.7, 72.4, 72-69 (Bn 495 
O-CH2-Ph), 36.52 (C-C4, min), 36.51 (C-C4, maj), 27.8 (C-F4, min), 27.5 (C-F4, maj). 496 




], 1574.5563; found, 1574.5579. FTIR 497 
(thin film): 3062, 3030, 2930, 2870, 1601, 1514, 1498, 1454, 1418, 1380, 1213, 1171, 1117, 498 
1027, 735, 697. 499 
4.2.9 (+)-catechin-4α→8-(+)-catechin (1). 500 
Using the conditions specified by Tarascou et al.,
13
 compound 5 (0.20 g, 0.13 mmol), 501 
Pd(OH)2/C (200 mg), and Et3N (180 L, 1.3 mmol) in EtOAc/MeOH (3 mL, 3 mL) were 502 
stirred at room temperature under an atmosphere of H2 for 20 hours. The solution was filtered 503 
over celite and the filter cake washed with EtOAc (3 × 2 mL) and MeOH (3 × 2 mL) and the 504 
resulting solution was concentrated in vacuo. Filtration of the residue over silica gel 505 
(acetone/MeOH 95:5) and concentration afforded the native procyanidin 1 as a yellow fluffy 506 
solid (56 mg, 76%), mp 216-221 
o




 Optical rotation: []25D= -507 
218 (c 0.36, EtOH), lit. []24D= -221 (c 0.38, EtOH).
18b
 The mp title compound 1 matched 508 
that reported by Tarascou et al.
13




C NMR and optical rotation [α]D data 509 
matched that reported by Saito et al.
18a,, 18b
 for the same compound. 510 
4.2.10 3,5,7,3´,4´-penta-O-benzyl-catechin-4β-(2-ethoxyethyl)ether-8-boronic acid (18). 511 
 22 
To a stirring solution of 6 (2.23 g, 2.46 mmol) in THF (30 mL) at 78 oC, n-BuLi (1.8 mL, 512 
1.50 M in hexanes, 2.70 mmol, 1.1 equiv.) was added dropwise over 2 minutes and the 513 
resulting yellow solution was stirred at this temperature for 15 minutes. Neat B(OMe)3 (360 514 
μL, 3.23 mmol, 1.3 equiv.) was then added dropwise at 78 oC over 5 minutes. The resulting 515 
mixture was then allowed to stir at this temperature for 1 hour, before being slowly warmed 516 
to 0 
o
C in the cold bath over 4 hours. Water (5 mL) was then added dropwise with stirring 517 
over 10 minutes before the mixture was poured into a stirring slurry of EtOAc (100 mL) and 518 
ice (ca. 50 g) and allowed to warm to room temperature over 30 minutes. The phases were 519 
then separated and the organics were washed sequentially with water (30 mL) and brine (30 520 
mL), then dried (Na2SO4), filtered and concentrated. Purification of the yellow residue by 521 
gradient silica chromatography (EtOAc/Hexanes 1:4 to 1:2) provided 1.11 g (52 %) of a 522 
white, foamy solid. 
1
H NMR (600 MHz, CDCl3) δ 7.48-7.26 (m, 20H), 7.19-7.17 (m, 3H), 523 
7.03-6.92 (m, 7H), 6.26 (s, 1H, C6-H), 5.34 (d, 1H, J = 10.2 Hz, C2-H), 5.22 (s, 2H, Ph- O-524 
CH2-Ph), 5.13-5.03 (m, 6H, 3 × Ph- O-CH2-Ph), 4.85 (d, 1H, J = 3 Hz, C4-H), 4.21 (d, 1H, J 525 
= 12 Hz, C3-O-CH2-Ph), 4.06 (d, 1H, J = 12 Hz, C3-O-CH2-Ph), 4.02 (m, 1H, C4-O-526 
CH2CH2-OEt), 3.82 (m, 1H, C4-O-CH2CH2-OEt), 3.60 (dd, 1H, J = 10.2 Hz and 3 Hz, C3-527 
H), 3.56 (m, 2H, C4-O-CH2CH2-OEt), 3.45 (q, 2H, J = 7.2 Hz, C4-OCH2CH2-O-CH2CH3), 528 
1.16 (t, 3H, J = 7.2 Hz, C4-O-CH2CH2-O-CH2CH3). 
13
C NMR (125 MHz, CDCl3) δ 166.0, 529 
160.8, 160.5, 149.2, 149.0, 137.4, 137.1, 137.0, 136.0, 135.3, 131.1, 130-126 (Benzyl Ar-H), 530 
120.9, 115.0, 113.8, 105.0, 91.0 (C6), 78.1 (C2), 76.2 (C3), 71.8 (C4), 71.3, 71.2, 71.1, 70.8, 531 
70.5, 69.8, 67.5, 66.3, 15.2 (C4-O-CH2CH2-O-CH2CH3). 
11
B NMR (126 MHz, CD3CN) δ 532 




], 895.3624, found 895.3627. FTIR 533 
(thin film): 3527, 3063, 3032, 2925, 2870, 1601, 1514, 1454, 1430, 1380, 1218, 1176, 1112, 534 
1027, 736, 697. 535 
4.2.11 3,5,7,3´,4´-penta-O-benzyl-catechin-4β-(2-ethoxyethyl)ether-8-(N-536 
methyliminodiacetyl)-boronate ester (19). 537 
To a stirring solution of 18 (1.11 g, 1.27 mmol) and N-methyliminodiacetic acid (0.38 g, 2.58 538 
mmol, 2 equiv.) in toluene/DMSO (25 mL/2.5 mL) at room temperature, solid CaH2 (0.53 g, 539 
12.6 mmol, 10 equiv.) was added and the resulting mixture was stirred at room temperature 540 
for 5 minutes before being refluxed at 120 
o
C for 16 hours. The mixture was cooled to room 541 
temperature and filtered over celite. The filter cake was washed with CH2Cl2 (3 × 10 mL) and 542 
the combined organics were washed with brine (4 × 50 mL), then dried (Na2SO4), filtered and 543 
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concentrated. The residue was purified by SiO2 chromatography (CH2Cl2, then CH2Cl2/Et2O 544 
90:10) to provide a white, amorphous solid (1.01 g, 80%). 
1
H NMR (600 MHz, CDCl3) δ 545 
7.51-7.26 (m, 20H), 7.20-7.19 (m, 4H), 7.00-6.93 (m, 4H), 6.17 (s, 1H, C6-H), 5.33 (d, 1H, J 546 
= 10.8 Hz, C2-H), 5.19-4.98 (m, 8H, 4 × Ph-O-CH2-Ph), 4.80 (br s, 1H, C4-H), 4.15 (dis m, 547 
1H, C3-O-CH2-Ph), 4.07 (dis m, 1H, C4-O-CH2CH2-OEt), 3.99 (dis m, 1H, C3-O-CH2-Ph), 548 
3.87 (dis m, 1H, C4-O-CH2CH2-OEt), 3.58 (dis m, 3H, C3-H and C4-O-CH2CH2-OEt), 3.5-549 
3.30 (overlapping m, 6H, C4-O-CH2CH2-O-CH2CH3 and 2 × B(MIDA)-CH2), 2.46 (s, 3H, 550 
B(MIDA)-N-CH3), 1.17 (t, 3H, C4-O-CH2CH2-O-CH2CH3). 
13
C NMR (125 MHz, CDCl3) δ 551 
167.94 (B(MIDA)-carbonyl), 167.86 (B(MIDA)-carbonyl), 164.9, 159.7, 159.6, 148.7, 552 
148.2, 137.6, 137.5, 137.2, 136.8, 136.5, 131.2, 130-126 (Benzyl Ar-H), 121.1, 114.4, 113.7, 553 
104.5, 92.1 (C6), 75.4 (C3), 71.8 (C2), 71.1 (O-CH2-Ph), 71.0 (2 × O-CH2-Ph), 70.9 (C4), 554 
70.3 (O-CH2-Ph), 70.1 (O-CH2-Ph), 69.9 (C4-O-CH2CH2-O-CH2CH3), 66.0 (2 × C4-O-555 
CH2CH2-OEt), 63.0 (B(MIDA)-CH2), 62.6 (B(MIDA)-CH2).  46.9 (B(MIDA)-N-CH3), 15.1 556 
(C4-OCH2CH2-OCH2CH3). 
11





], 1006.3944, found 1006.3950. FTIR (thin film): 3062, 3031, 558 
2926, 2869, 1766, 1595, 1496, 1451, 1429, 1301, 1265, 1209, 1126, 1090, 1028, 838, 737, 559 
698. 560 
4.2.12 3,5,7,3´,4´-penta-O-benzyl-catechin-8-(N-methyliminodiacetyl)-boronate ester-561 
4α→8-3,5,7,3´,4´-penta-O-benzyl-catechin (20). 562 
To a stirring solution of 19 (0.61 g, 0.62 mmol) and 16 (0.55 g, 0.70 mmol) in THF (20 mL) 563 
at 78 oC, neat TMSOTf (130 μL, 0.72 mmol) was added dropwise at this temperature and 564 
stirring was continued at 78 oC for 1 hour. The mixture was allowed to slowly warm in the 565 
cold bath to room temperature over 3 hours. Sat. aq. NaHCO3 (5 mL) was added and the 566 
resulting mixture was stirred vigorously for 10 minutes and then extracted with EtOAc (2 × 567 
20 mL). The combined organics were then sequentially washed with water (20 mL) and brine 568 
(20 mL), dried (Na2SO4), filtered and concentrated. Silica gel chromatography of the residue 569 
(CH2Cl2 then CH2Cl2/Et2O 9:1) provided 0.95 g (94%) of a white, amorphous solid. 
1
H NMR 570 
(600 MHz, CDCl3, two rotamers: maj/min ~75:25) δ 7.53-7.12 (m, Ar-H, maj and min) 7.04-571 
6.81 (m, B, E-ring-H, maj and min), 6.68 (s), 6.63 (d, J = 7.4 Hz, min) 6.59 (d, J = 7.4 maj), 572 
6.22 (s, D6-H, min), 6.16 (s, D6-H, maj), 6.13 (s, C6-H, maj), 6.12 (s, C6-H, min), 5.36 (d, J 573 
= 12Hz, O-CH2-Ph), 5.20-4.74 (m, O-CH2-Ph overlapping with C4-H, maj and min), 4.65 574 
(d, J = 11 Hz, O-CH2-Ph, maj) 4.53 (d, J = 11.0 Hz, O-CH2-Ph), 4.40 (d, J = 9.3 Hz, C2-H, 575 
 24 
maj), 4.22 (d, J = 12.4 Hz, O-CH2-Ph, maj and min), 4.14 (d, J = 12.4 Hz, O-CH2-Ph, maj), 576 
4.08 (overlapping dd, J = 9.2 Hz, C3-H, maj), 3.73 (d, J = 9.2 Hz, F2-H, maj), 3.47-3.19 (m, 577 
overlapping F3-H, F-4H, MIDA-CH2, maj and min), 2.48 (dd, J = 15.9 and 9.9 Hz, F4-H, 578 
maj), 2.37 (s, MIDA-N-CH3). 
13
C NMR (125 MHz, CDCl3, major isomer only) δ 167.9, 579 
167.8 (2 × MIDA-carbonyl), 162.4, 160.9, 158.9, 155.2, 155.1, 153.9, 148.9, 148.8, 148.3, 580 
148.0, 138.5-136 (Bn CqPh), 133.3, 131.7, 129-126 (Benzyl Ar-H),  120.7, 120.5, 114.5, 581 
114.2, 112.6 (C-A8), 109.8, 104.1, 102.4, 93.9 (C-A6) , 91.7 (C-D6), 81.8 (C-C2), 80.7 (C-582 
F2), 79.2, 75.2, 74.1, 72.1, 71.3-69.8 (Benzyl O-CH2-Ph), 63.2, 63.1 (2 × MIDA-CH2), 46.9 583 
(MIDA-N-CH3), 36.7 (C-C4), 27.6 (C-F4). 
11
B NMR (126 MHz, CD3CN) δ 13.5. HRMS 584 




], 1656.6401, found 1656.6409. 585 
4.2.13 3,5,7,3´,4´-penta-O-benzyl-catechin-8-boronic acid-4α→8-3,5,7,3´,4´-penta-O-586 
benzyl-catechin (17). 587 
To a stirring solution of 20 (0.39 g, 0.24 mmol) in THF (20 mL) at room temperature, dilute 588 
aq. NaOH (1 M, 4 mL) was added. The resulting mixture was vigorously stirred at room 589 
temperature under ambient atmospheric conditions for 2 hours. The reaction mixture was 590 
then poured into a mixture of pH = 7 buffer (10 mL) and CHCl3 (30 mL), stirred vigorously 591 
for 10 minutes and the phases were separated. The aqueous phase was extracted with CHCl3 592 
(2 × 20 mL). The combined organics were dried (Na2SO4), filtered and concentrated. 593 
Filtration of the residue over SiO2 (EtOAc/Hexanes 1:2) provided 0.31 g (85%) of the crude 594 





1540.6527, found 1540.6578. 596 
4.2.14 3,5,7,3´,4´-penta-O-benzyl-catechin-8-(N-methyliminodiacetyl)-boronate ester -597 
4α→8-3,5,7,3´,4´-penta-O-benzyl-catechin-4α→8-3,5,7,3´,4´-penta-O-benzyl-catechin 598 
(21). 599 
To the crude boronic acid 17 (92 mg, 60 mol), 19 (52 mg, 53 mol) was added and the 600 
mixture was dissolved with stirring in THF (3 mL), and then cooled to 78 oC. Neat TMSOTf 601 
(11 L, 61 mol) was added dropwise at 78 oC and stirring was continued at this 602 
temperature for 1 hour. The solution was allowed to slowly warm in the cold bath to room 603 
temperature over 3 hours. Sat. aq. NaHCO3 (5 mL) was added and the resulting mixture was 604 
stirred vigorously for 10 minutes. The aqueous phase was extracted with EtOAc (2 × 20 mL). 605 
The combined organics were sequentially washed with water (20 mL) and brine (20 mL), 606 
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then dried (Na2SO4), filtered and concentrated. Silica gel chromatography of the residue 607 
(CH2Cl2 then CH2Cl2/Et2O 9:1) provided 113 mg (90%) of a white, amorphous solid. 
1
H 608 
NMR (600 MHz, CDCl3, multiple rotamers) 7.5-7.24 (m, Benzyl Ar-H), 7.24-6.5 (m, 609 
Benzyl Ar-H, B, E, H ring protons, maj and min), 6.21 (s, D-6 maj), 6.17 (s, G-6 maj), 6.16-610 
6.04 (m, A-6, D-6, G-6, minor isomers)  5.85 (s, A-6 maj), 5.5-4.5 (m, Benzyl CH2, C-2, F-611 
2, I-2, maj and min), 4.5-4.0 (m, Benzyl CH2, C-3, F-3, C-4, maj and min), 3.6-3.1 (m, I-3, 612 
F-4, MIDA CH2), unable to definitively identify H-4 protons and MIDA N-CH3 due to 613 
impurity interferences. 
13
C NMR (125 MHz, CDCl3, mixture of rotamers) 167.9 (MIDA-614 
carbonyl), 167.8, (MIDA-carbonyl), 162.2, 131.4, 159.2, 155-154 (B, E, H ring 615 
quaternaries), 148.9-147.6 (D, G ring quaternaries), 139-131 (Benzyl quaternaries, ), 130-126 616 
(Benzyl Ar-H), 121.1, 120.9, 114.8, 114.1, 113.2, 112.8 (D8), 112.6 (G8), 110.6, 108.9, 617 
108.8, 106.7, 106.2 102.0, 100.69, 100.65, 100.3, 93.9 (C6), 92-90 (D6, D8, G6, G8), 82.7-618 
79.7 (C2, F2, I2, C3, maj and min), 74-68 (Benzyl CH2, F3, I3, maj and min), 63.3 (MIDA-619 
CH2), 61.3 (MIDA-CH2), 58.5, 47.0 (MIDA-N-CH3), 37.2 (C4 or F4), 36.9 (C4 or F4), 620 
unable to definitively identify C-I4 due to impurity interferences. 
11
B NMR (126 MHz, 621 
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